The US government is poised to provide a massive $2.7 billion boost to the domestic uranium enrichment sector as part of efforts to reduce reliance on Russian nuclear fuel imports. The funding, requested by the White House, is included in a broad government funding bill unveiled Sunday.
With the House already approving the 2024 appropriations package containing this funding Wednesday, the bill now heads to the Senate for expected final passage by Friday.
Breaking!💥🔨 US House has voted 339 to 85 to pass the 6-bill 2024 appropriations package today🧑⚖️🗳️✔️ that includes $2.7 Billion to boost domestic production of LEU and HALEU #Nuclear fuel💰⚛️🏭🇺🇸 and fund DoE's direct purchases of mined #Uranium from US producers⛏️🛒 under the… https://t.co/T6kXG9b14V
— John Quakes (@quakes99) March 6, 2024
The sizable investment aims to revitalize America’s largely dormant uranium enrichment capabilities by guaranteeing a market for domestically produced nuclear reactor fuel. President Joe Biden’s administration plans to directly purchase enriched uranium from US producers under this initiative.
The move comes amid growing momentum to ban imports of enriched uranium from Russia, which was the top foreign supplier to the US in 2022. Both the House and Senate are considering legislation to prohibit such imports from Russia.
Yes. The US Senate is said to unanimously support the House bill passed in December to ban imports of Russian enriched #Uranium but holding the vote has been dependent on this $2.7B funding being approved to boost US production to replace banned Russian supply. Once funding is in…
— John Quakes (@quakes99) March 6, 2024
The $2.7 billion allocation would be repurposed from a credit program originally intended for domestic nuclear reactors under the 2022 bipartisan infrastructure law. Funds are earmarked to support the enrichment of uranium for the nation’s fleet of over 90 nuclear power plants, as well as highly enriched uranium for next-generation advanced reactors currently only produced in Russia.
Information for this story was found via Bloomberg, and the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.